CareDx to Participate at the Goldman Sachs Global Healthcare Conference
CareDx, a precision medicine company focused on transplant patient solutions, announced its participation in the Goldman Sachs Global Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareDx, a precision medicine company focused on transplant patient solutions, announced its participation in the Goldman Sachs Global Healthcare Conference. The management will engage in a fireside chat on June 9, 2020, at 11:20 AM EDT. Interested stakeholders can access a live webcast through the company’s website. CareDx specializes in products and services that enhance the pre- and post-transplant experience, providing genomics-based information vital for transplant patients.
Details
News Market Reaction – CDNA
The recorded move for CDNA in the trading session of this news was -3.19%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the company will be participating in the upcoming Goldman Sachs Global Healthcare Conference.
CareDx’s management is scheduled to take part in a fireside chat on Tuesday, June 9, 2020, at 11:20 AM Eastern Daylight Time (EDT). Interested parties may access a live webcast of the presentation on the “Investors” section of the company’s website at https://investors.caredxinc.com/.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
For more information, please visit: www.CareDx.com.
CONTACTS:
Greg Chodaczek
347-620-7010
investor@caredx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.